NDAORALCAPSULE, EXTENDED RELEASE
Approved
Aug 1976
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
4/8 — Partial
DEXEDRINE SPANSULE (dextroamphetamine sulfate) by R-Pharm US is clinical pharmacology amphetamines are noncatecholamine, sympathomimetic amines with cns stimulant activity. Approved for attention deficit hyperactivity disorder. First approved in 1976.
Drug data last refreshed Yesterday
Mechanism of Action
CLINICAL PHARMACOLOGY Amphetamines are noncatecholamine, sympathomimetic amines with CNS stimulant activity. Peripheral actions include elevations of systolic and diastolic blood pressures and weak bronchodilator and respiratory stimulant action. There is neither specific evidence that clearly…
Indications (1)
Worked on DEXEDRINE SPANSULE at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.